Correlation of Coronary Artery Disease and Left Ventricular Hypertrophy

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Pathophysiology

Background:

• Ischemic heart disease (IHD) is the primary cause of global mortality, stemming from myocardial oxygen supply-demand imbalance.
• Coronary artery disease (CAD) reduces oxygen supply, while left ventricular hypertrophy (LVH) increases oxygen demand, both contributing to IHD.
• Hypertension is a common precursor to both CAD and LVH, highlighting the interconnectedness of these conditions.

Purpose of the Study:

• To investigate the detrimental effects of the combined presence of CAD and LVH on myocardial ischemia.
• To establish a causal link between CAD, LVH, and increased mortality risk.
• To explore novel prevention and management strategies for IHD in patients with coexisting CAD and LVH.

Main Methods:

• Utilizing noninvasive echocardiography to assess left ventricular (LV) mass as an indicator of coronary artery stenosis severity.
• Analyzing clinical data to correlate LV mass with coronary artery disease extent.
• Reviewing current therapeutic approaches, including the use of angiotensin-converting enzyme inhibitors and diuretics, for managing CAD and LVH.

Main Results:

• The coexistence of CAD and LVH significantly exacerbates myocardial oxygen deficit.
• Eccentric LVH, in particular, is associated with increased morbidity and mortality from myocardial infarction.
• LV mass on echocardiography can serve as a surrogate marker for coronary artery stenosis, aiding clinical decision-making.

Conclusions:

• Controlling predisposing factors like hypertension is crucial for preventing or reversing LVH, thereby mitigating IHD risk.
• Management strategies should focus on addressing both CAD and LVH concurrently.
• New therapeutic interventions targeting the interplay between CAD and LVH are essential for improving patient outcomes in ischemic heart disease.